JASON SMITH: Open Payments
NPI 1699290296 · MERIDIAN, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,024 in 47 payments from 13 companies in 2025. Trend: 2023 $1,534 · 2024 $1,079 · 2025 $1,024
Food & beverage: $870Education: $154
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 14 | $215 |
| ABBVIE INC. | 9 | $180 |
| LEO Pharma Inc. | 3 | $127 |
| UCB, Inc. | 5 | $93 |
| Janssen Biotech, Inc. | 2 | $87 |
| SANOFI-AVENTIS U.S. LLC | 1 | $85 |
| GENZYME CORPORATION | 4 | $78 |
| Incyte Corporation | 3 | $55 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $30 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $26 |
Products named: DUPIXENT, SKYRIZI, ANZUPGO, Bimzelx, TREMFYA, COSENTYX, OPZELURA, RINVOQ.
Industry payments across ID — which companies pay providers there.
